TAMMY GARCIA: Open Payments
NPI 1942560180 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 22 payments from 5 companies in 2025. Trend: 2023 $1,170 · 2024 $373 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $349 |
| ABBVIE INC. | 11 | $323 |
| Janssen Pharmaceuticals, Inc | 5 | $141 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
